Berlin - Delayed Quote EUR
AbbVie Inc (4AB.BE)
168.60
-2.80
(-1.63%)
At close: May 13 at 9:48:25 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
16,401,000
18,806,000
22,839,000
24,943,000
22,777,000
Investing Cash Flow
-11,967,000
-20,820,000
-2,009,000
-623,000
-2,344,000
Financing Cash Flow
-17,288,000
-5,211,000
-17,222,000
-24,803,000
-19,039,000
End Cash Position
5,213,000
5,524,000
12,814,000
9,201,000
9,746,000
Income Tax Paid Supplemental Data
--
4,064,000
4,702,000
2,988,000
3,648,000
Interest Paid Supplemental Data
--
2,811,000
2,469,000
2,546,000
2,712,000
Capital Expenditure
-1,016,000
-974,000
-777,000
-695,000
-787,000
Issuance of Debt
7,587,000
21,971,000
0
2,000,000
1,000,000
Repayment of Debt
-12,539,000
-14,621,000
-4,149,000
-14,433,000
-9,414,000
Repurchase of Capital Stock
-1,345,000
-1,708,000
-1,972,000
-1,487,000
-934,000
Free Cash Flow
15,385,000
17,832,000
22,062,000
24,248,000
21,990,000
12/31/2021 - 2/14/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0R1F.IL Bristol-Myers Squibb Company
48.20
+3.05%
MRK.VI Merck & Co., Inc.
69.30
-3.21%
JNJd.XC
AMG.F Amgen Inc.
246.65
+7.10%
AZN.L AstraZeneca PLC
10,180.00
-0.90%
GSK.L GSK plc
1,358.00
-2.97%
JNJ Johnson & Johnson
148.44
-3.70%
LLY Eli Lilly and Company
746.06
-1.26%
MRK Merck & Co., Inc.
76.63
-4.72%
NVO Novo Nordisk A/S
65.40
-3.45%